Etiologies of severe acute respiratory infection (SARI) and misdiagnosis of influenza in Indonesia, 2013-2016.


Journal

Influenza and other respiratory viruses
ISSN: 1750-2659
Titre abrégé: Influenza Other Respir Viruses
Pays: England
ID NLM: 101304007

Informations de publication

Date de publication:
01 2021
Historique:
received: 14 08 2019
revised: 02 03 2020
accepted: 18 06 2020
pubmed: 16 7 2020
medline: 26 11 2021
entrez: 16 7 2020
Statut: ppublish

Résumé

Severe acute respiratory infection (SARI) accounts for a large burden of illness in Indonesia. However, epidemiology of SARI in tertiary hospitals in Indonesia is unknown. This study sought to assess the burden, clinical characteristics, and etiologies of SARI and concordance of clinical diagnosis with confirmed etiology. Data and samples were collected from subjects presenting with SARI as part of the acute febrile Illness requiring hospitalization study (AFIRE). In tertiary hospitals, clinical diagnosis was ascertained from chart review. Samples were analyzed to determine the "true" etiology of SARI at hospitals and Indonesia Research Partnership on Infectious Diseases (INA-RESPOND) laboratory. Distribution and characteristics of SARI by true etiology and accuracy of clinical diagnosis were assessed. Four hundred and twenty of 1464 AFIRE subjects presented with SARI; etiology was identified in 242 (57.6%), including 121 (28.8%) viruses and bacteria associated with systemic infections, 70 (16.7%) respiratory bacteria and viruses other than influenza virus, and 51 (12.1%) influenza virus cases. None of these influenza patients were accurately diagnosed as having influenza during hospitalization. Influenza was misdiagnosed among all patients presenting with SARI to Indonesian tertiary hospitals in the AFIRE study. Diagnostic approaches and empiric management should be guided by known epidemiology. Public health strategies to address the high burden of influenza should include broad implementation of SARI screening, vaccination programs, clinician education and awareness campaigns, improved diagnostic capacity, and support for effective point-of-care tests.

Sections du résumé

BACKGROUND
Severe acute respiratory infection (SARI) accounts for a large burden of illness in Indonesia. However, epidemiology of SARI in tertiary hospitals in Indonesia is unknown. This study sought to assess the burden, clinical characteristics, and etiologies of SARI and concordance of clinical diagnosis with confirmed etiology.
METHODS
Data and samples were collected from subjects presenting with SARI as part of the acute febrile Illness requiring hospitalization study (AFIRE). In tertiary hospitals, clinical diagnosis was ascertained from chart review. Samples were analyzed to determine the "true" etiology of SARI at hospitals and Indonesia Research Partnership on Infectious Diseases (INA-RESPOND) laboratory. Distribution and characteristics of SARI by true etiology and accuracy of clinical diagnosis were assessed.
RESULTS
Four hundred and twenty of 1464 AFIRE subjects presented with SARI; etiology was identified in 242 (57.6%), including 121 (28.8%) viruses and bacteria associated with systemic infections, 70 (16.7%) respiratory bacteria and viruses other than influenza virus, and 51 (12.1%) influenza virus cases. None of these influenza patients were accurately diagnosed as having influenza during hospitalization.
CONCLUSIONS
Influenza was misdiagnosed among all patients presenting with SARI to Indonesian tertiary hospitals in the AFIRE study. Diagnostic approaches and empiric management should be guided by known epidemiology. Public health strategies to address the high burden of influenza should include broad implementation of SARI screening, vaccination programs, clinician education and awareness campaigns, improved diagnostic capacity, and support for effective point-of-care tests.

Identifiants

pubmed: 32666619
doi: 10.1111/irv.12781
pmc: PMC7405185
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

34-44

Subventions

Organisme : NCI NIH HHS
ID : HHSN261200800001E
Pays : United States
Organisme : NCI NIH HHS
ID : HHSN261201500003I
Pays : United States

Informations de copyright

© 2020 The Authors. Influenza and Other Respiratory Viruses Published by John Wiley & Sons Ltd.

Références

Influenza Other Respir Viruses. 2013 May;7(3):312-20
pubmed: 22804910
J Trop Med. 2012;2012:120496
pubmed: 23304167
PLoS One. 2017 Jul 13;12(7):e0180954
pubmed: 28704440
Vaccine. 2018 Jun 22;36(27):3960-3966
pubmed: 29801998
PLoS One. 2017 Jul 14;12(7):e0180920
pubmed: 28708896
Neth J Med. 2012 Jun;70(5):215-21
pubmed: 22744922
Pediatr Infect Dis J. 2018 Nov;37(11):1077-1081
pubmed: 29601448
Influenza Other Respir Viruses. 2017 Mar;11(2):148-156
pubmed: 27465959
J Clin Microbiol. 2016 Jan;54(1):197-9
pubmed: 26511741
PLoS One. 2018 Nov 21;13(11):e0205124
pubmed: 30462659
BMC Fam Pract. 2017 Mar 16;18(1):37
pubmed: 28302056
Influenza Other Respir Viruses. 2018 Jan;12(1):81-87
pubmed: 29205865
Influenza Other Respir Viruses. 2016 Jul;10(4):333-9
pubmed: 27219455
Clin Infect Dis. 2004 Aug 15;39(4):443-9
pubmed: 15356802
Microbes Infect. 2016 Apr;18(4):270-6
pubmed: 26706819
J Pediatric Infect Dis Soc. 2017 Sep 1;6(3):297-300
pubmed: 27496537
J Clin Microbiol. 2016 Dec 28;55(1):79-89
pubmed: 27795341
PLoS Negl Trop Dis. 2020 Jan 10;14(1):e0007927
pubmed: 31923174
Korean J Intern Med. 2018 Mar;33(2):391-396
pubmed: 29117669
BMC Infect Dis. 2015 Feb 25;15:95
pubmed: 25879805
Arch Intern Med. 2011 Jan 24;171(2):151-7
pubmed: 21263105
J Clin Microbiol. 2007 May;45(5):1523-7
pubmed: 17376878
J Hosp Infect. 2014 Mar;86(3):188-93
pubmed: 24468292
Biomed Res Int. 2017;2017:9541619
pubmed: 28232948
Jpn J Infect Dis. 2017 Sep 25;70(5):522-527
pubmed: 28367882
J Infect Prev. 2017 Jul;18(4):193-198
pubmed: 28989527
Bull World Health Organ. 2018 Feb 1;96(2):122-128
pubmed: 29403115
Int Marit Health. 2018;69(2):149-150
pubmed: 29939393
Disaster Med Public Health Prep. 2016 Dec;10(6):838-847
pubmed: 27298195
Am J Trop Med Hyg. 2014 Sep;91(3):451-60
pubmed: 24957537
Microbiol Insights. 2018 Feb 13;11:1178636118758651
pubmed: 29467579
PLoS Negl Trop Dis. 2019 Jan 14;13(1):e0007084
pubmed: 30640900
Lancet. 1998 Nov 21;352(9141):1712
pubmed: 9853477
Influenza Other Respir Viruses. 2013 May;7(3):321-9
pubmed: 22804843
PLoS Negl Trop Dis. 2017 Apr 5;11(4):e0005520
pubmed: 28379967
Epidemiol Infect. 2016 Aug;144(11):2306-16
pubmed: 27018720
Methods Mol Biol. 2018;1836:23-31
pubmed: 30151567
Br J Gen Pract. 2014 Dec;64(629):604-5
pubmed: 25452508

Auteurs

Abu Tholib Aman (AT)

Department of Microbiology, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada / Dr. Sardjito Hospital, Yogyakarta, Indonesia.
Indonesia Research Partnership on Infectious Diseases (INA-RESPOND), Jakarta, Indonesia.

Tri Wibawa (T)

Department of Microbiology, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada / Dr. Sardjito Hospital, Yogyakarta, Indonesia.
Indonesia Research Partnership on Infectious Diseases (INA-RESPOND), Jakarta, Indonesia.

Herman Kosasih (H)

Indonesia Research Partnership on Infectious Diseases (INA-RESPOND), Jakarta, Indonesia.

Rizka Humardewayanti Asdie (RH)

Indonesia Research Partnership on Infectious Diseases (INA-RESPOND), Jakarta, Indonesia.
Department of Internal Medicine, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada / Dr. Sardjito Hospital, Yogyakarta, Indonesia.

Ida Safitri (I)

Indonesia Research Partnership on Infectious Diseases (INA-RESPOND), Jakarta, Indonesia.
Department of Pediatric, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada / Dr. Sardjito Hospital, Yogyakarta, Indonesia.

Umi Solekhah Intansari (US)

Indonesia Research Partnership on Infectious Diseases (INA-RESPOND), Jakarta, Indonesia.
Department of Clinical Pathology, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada / Dr. Sardjito Hospital, Yogyakarta, Indonesia.

Yuli Mawarti (Y)

Department of Microbiology, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada / Dr. Sardjito Hospital, Yogyakarta, Indonesia.
Indonesia Research Partnership on Infectious Diseases (INA-RESPOND), Jakarta, Indonesia.

Pratiwi Sudarmono (P)

Cipto Mangunkusumo Hospital, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.

Mansyur Arif (M)

Faculty of Medicine, Universitas Hasanudin / Dr. Wahidin Sudirohusodo Hospital, Makassar, Indonesia.

Dwiyanti Puspitasari (D)

Dr. Soetomo Academic General Hospital, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.

Bachti Alisjahbana (B)

Faculty of Medicine, Universitas Padjadjaran / Dr. Hasan Sadikin Hospital, Sumedang, Indonesia.

Ketut Tuti Merati Parwati (KTM)

Medical Faculty, Udayana University and Sanglah General Hospital, Denpasar, Indonesia.

Muhammad Hussein Gasem (MH)

Dr. Kariadi Hospital / Diponegoro University, Semarang, Indonesia.

Dewi Lokida (D)

Tangerang District Hospital, Tangerang, Indonesia.

Nurhayati Lukman (N)

Indonesia Research Partnership on Infectious Diseases (INA-RESPOND), Jakarta, Indonesia.

Teguh Sarry Hartono (TS)

Indonesia Research Partnership on Infectious Diseases (INA-RESPOND), Jakarta, Indonesia.
Sulianti Saroso Hospital, Jakarta, Indonesia.

Yan Mardian (Y)

Indonesia Research Partnership on Infectious Diseases (INA-RESPOND), Jakarta, Indonesia.

C Jason Liang (CJ)

National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Bethesda, MD, USA.

Sophia Siddiqui (S)

Indonesia Research Partnership on Infectious Diseases (INA-RESPOND), Jakarta, Indonesia.
National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Bethesda, MD, USA.

Muhammad Karyana (M)

Indonesia Research Partnership on Infectious Diseases (INA-RESPOND), Jakarta, Indonesia.
National Institute of Health Research and Development (NIHRD), Ministry of Health, Jakarta, Indonesia.

Chuen-Yen Lau (CY)

Indonesia Research Partnership on Infectious Diseases (INA-RESPOND), Jakarta, Indonesia.
National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Bethesda, MD, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH